ChangChun High New Technology Industries operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares ChangChun High New Technology Industries with three other
companies in this sector in CHINA :
Apeloa Pharmaceutical Co Ltd
sales of 7.21 billion Chinese Renmimbi [US$1.01 billion]
of which 100%
was Health Care & Pharmaceutical),
Zhejiang Nhu Co Ltd
(7.62 billion Chinese Renmimbi [US$1.07 billion]
of which 94%
was Pharmaceutical Chemicals), and
Shandong Xinhua Pharmaceutical Company Limited
(5.61 billion Chinese Renmimbi [US$785.46 million]
of which 57%
During the year ended December of 2019, sales at
ChangChun High New Technology Industries were 7.27 billion Chinese Renmimbi (US$1.02 billion).
increase of 36.7%
versus 2018, when the company's sales were 5.32 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at ChangChun High New Technology Industries
(and since 2014, sales have increased a total of 226%).
Sales of Real Estates saw an increase
57.7% in 2019, from
606.83 million Chinese Renmimbi to 956.78 million Chinese Renmimbi.
Not all segments of ChangChun High New Technology Industries experienced an increase in sales in 2019:
sales of Service Industry fell 43.8% to 14.29 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).